G03AB03 • levonorgestrel + ethinyl estradiol • Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, sequential preparations
The combination of levonorgestrel and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Levonorgestrel is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.
The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.
Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.
This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.
Substance: levonorgestrel + ethinyl estradiol
Date of last drug list: 01-01-2014
Commercial code: W53385001
Pharmaceutical form: dragees
Quantity: 1
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.